Medizinische Universit├Ąt Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Buzina, W.
Aspergillus--classification and antifungal susceptibilities.
Curr Pharm Des. 2013; 19(20):3615-3628 Doi: 10.2174/1381612811319200005
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Buzina Walter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Aspergillus is one of the most important fungal genera for the man, for its industrial use, its ability to spoil food and not least its medical impact as cause of a variety of diseases. Currently hundreds of species of Aspergillus are known; nearly fifty of them are able to cause infections in humans and animals. Recently, the genus Aspergillus is subdivided into 8 subgenera and 22 sections. The spectrum of diseases caused by Aspergillus species varies from superficial cutaneous to invasive and systemic infections. All species of Aspergillus investigated so far are resistant against the antifungals fluconazole and 5-fluorocytosine, the range of susceptibilities to currently available antifungals is discussed in this paper.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Antifungal Agents - pharmacology
Aspergillosis - drug therapy
Aspergillus - classification
Drug Resistance, Fungal -
Fluconazole - pharmacology
Flucytosine - pharmacology
Humans -

Find related publications in this database (Keywords)
Aspergillus
susceptibility
antifungals
antimycotic drugs
© Med Uni GrazImprint